De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants

Rothmund-Thomson syndrome (RTS) is a rare autosomal-recessive disorder with clinical features consisting of rash, poikiloderma, sparse hair, short stature, juvenile cataracts, skeletal abnormalities, and cancer predisposition. Genetic studies involving detection of pathogenic RECQL4 variants provide...

Full description

Bibliographic Details
Main Authors: Chuanhe Jiang, Hao Zhang, Chuxian Zhao, Luxiang Wang, Xiaoxia Hu, Zengkai Pan
Format: Article
Language:English
Published: Wolters Kluwer Health 2023-04-01
Series:Blood Science
Online Access:http://journals.lww.com/10.1097/BS9.0000000000000152
_version_ 1797817598182686720
author Chuanhe Jiang
Hao Zhang
Chuxian Zhao
Luxiang Wang
Xiaoxia Hu
Zengkai Pan
author_facet Chuanhe Jiang
Hao Zhang
Chuxian Zhao
Luxiang Wang
Xiaoxia Hu
Zengkai Pan
author_sort Chuanhe Jiang
collection DOAJ
description Rothmund-Thomson syndrome (RTS) is a rare autosomal-recessive disorder with clinical features consisting of rash, poikiloderma, sparse hair, short stature, juvenile cataracts, skeletal abnormalities, and cancer predisposition. Genetic studies involving detection of pathogenic RECQL4 variants provide the diagnostic certitude. Osteosarcoma was found in two-thirds RECQL4-mutated RTS patients, while hematological malignancies were rarely reported. The variant diversity of RECQL4 gene has not been fully identified and mutations associated with hematologic malignancies are not well described. In this study, we presented a pedigree of RTS from a Chinese family, among which the proband was diagnosed with de novo myelodysplastic syndrome (MDS). Comprehensive medical examination and chromosome karyotyping were performed on the proband. Whole exome sequencing (WES) was performed on the proband, his sister and his mother. The familial cosegregation of sequence variants derived from WES was conducted by polymerase chain reaction–based Sanger sequencing. Structures of candidate RECQL4 mutants were done by in silico analysis to assess pathogenicity. Three novel RECQL4 germline variants, including c.T274C, c.G3014A, and c.G801C, were identified by WES and validated by Sanger sequencing. Prediction of conformation indicated that the structural stability of human RECQL4 protein was largely affected with these variants. The co-occurring U2AF1 p.S34F and TP53 p.Y220C mutations might contribute to the development of MDS. Our study expands the mutational spectrum of RECQL4 and provides underlying molecular mechanism for the development of MDS in RTS patients.
first_indexed 2024-03-13T08:55:54Z
format Article
id doaj.art-ea7bd5ee5593442ca4b3170566256c0b
institution Directory Open Access Journal
issn 2543-6368
language English
last_indexed 2024-03-13T08:55:54Z
publishDate 2023-04-01
publisher Wolters Kluwer Health
record_format Article
series Blood Science
spelling doaj.art-ea7bd5ee5593442ca4b3170566256c0b2023-05-29T03:32:21ZengWolters Kluwer HealthBlood Science2543-63682023-04-015212513010.1097/BS9.0000000000000152202304000-00008De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variantsChuanhe Jiang0Hao Zhang1Chuxian Zhao2Luxiang Wang3Xiaoxia Hu4Zengkai Pan5a National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, Chinaa National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, Chinab Shanghai Zhaxin Traditional Chinese & Western Medicine Hospital, Shanghai 200435, Chinaa National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, Chinaa National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, Chinaa National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaRothmund-Thomson syndrome (RTS) is a rare autosomal-recessive disorder with clinical features consisting of rash, poikiloderma, sparse hair, short stature, juvenile cataracts, skeletal abnormalities, and cancer predisposition. Genetic studies involving detection of pathogenic RECQL4 variants provide the diagnostic certitude. Osteosarcoma was found in two-thirds RECQL4-mutated RTS patients, while hematological malignancies were rarely reported. The variant diversity of RECQL4 gene has not been fully identified and mutations associated with hematologic malignancies are not well described. In this study, we presented a pedigree of RTS from a Chinese family, among which the proband was diagnosed with de novo myelodysplastic syndrome (MDS). Comprehensive medical examination and chromosome karyotyping were performed on the proband. Whole exome sequencing (WES) was performed on the proband, his sister and his mother. The familial cosegregation of sequence variants derived from WES was conducted by polymerase chain reaction–based Sanger sequencing. Structures of candidate RECQL4 mutants were done by in silico analysis to assess pathogenicity. Three novel RECQL4 germline variants, including c.T274C, c.G3014A, and c.G801C, were identified by WES and validated by Sanger sequencing. Prediction of conformation indicated that the structural stability of human RECQL4 protein was largely affected with these variants. The co-occurring U2AF1 p.S34F and TP53 p.Y220C mutations might contribute to the development of MDS. Our study expands the mutational spectrum of RECQL4 and provides underlying molecular mechanism for the development of MDS in RTS patients.http://journals.lww.com/10.1097/BS9.0000000000000152
spellingShingle Chuanhe Jiang
Hao Zhang
Chuxian Zhao
Luxiang Wang
Xiaoxia Hu
Zengkai Pan
De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants
Blood Science
title De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants
title_full De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants
title_fullStr De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants
title_full_unstemmed De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants
title_short De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants
title_sort de novo myelodysplastic syndrome in a rothmund thomson syndrome patient with novel pathogenic recql4 variants
url http://journals.lww.com/10.1097/BS9.0000000000000152
work_keys_str_mv AT chuanhejiang denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants
AT haozhang denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants
AT chuxianzhao denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants
AT luxiangwang denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants
AT xiaoxiahu denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants
AT zengkaipan denovomyelodysplasticsyndromeinarothmundthomsonsyndromepatientwithnovelpathogenicrecql4variants